- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02665182
Up-positioning of the Testes as Supportive Therapy in Patients With Acute Orchitis (EleScro)
December 27, 2018 updated by: Medical University of Warsaw
Up-positioning of the Testes as Supportive Therapy in Patients With Acute Orchitis - a Randomized Controlled Trial
This is a single-blinded RCT evaluating the value of up-positioning of the testes as supportive therapy in patients receiving antimicrobial treatment due to acute bacterial orchitis.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Warsaw, Poland, 02005
- Sławomir Poletajew
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- acute orchitis confirmed clinically and in scrotal ultrasound
- age >=18 yrs
Exclusion Criteria:
- previous treatment of orchitis,
- need for exploration of the scrotum,
- need for hospitalization,
- physical and mental status not allowing for up-positioning of the testes during treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Up-positioning of the testes
Patients receive standard medical therapy and supportive therapy
|
Patients in the experimental arm are asked to elevate their testes during the treatment.
|
No Intervention: Medical therapy only
Patients receive standard medical therapy only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time to alleviation of symptoms
Time Frame: 10 days
|
10 days
|
Time to clinical resolution of local symptoms
Time Frame: 10 days
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Testicular pain
Time Frame: 10 days
|
10 days
|
Testicular swelling
Time Frame: 10 days
|
10 days
|
Testicular erythema
Time Frame: 10 days
|
10 days
|
Scrotal pain intensity
Time Frame: 10 days
|
10 days
|
Quality of life
Time Frame: 10 days
|
10 days
|
Body temperature
Time Frame: 10 days
|
10 days
|
Heart rate
Time Frame: 10 days
|
10 days
|
Duration of up-positioning of testes per day
Time Frame: 10 days
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sławomir Poletajew, MD PhD, Medical University of Warsaw
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Anticipated)
January 1, 2020
Study Completion (Anticipated)
January 1, 2021
Study Registration Dates
First Submitted
January 22, 2016
First Submitted That Met QC Criteria
January 26, 2016
First Posted (Estimate)
January 27, 2016
Study Record Updates
Last Update Posted (Actual)
December 28, 2018
Last Update Submitted That Met QC Criteria
December 27, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SP12-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Testicular Diseases
-
Haukeland University HospitalKarolinska University Hospital; Oslo University Hospital; University Hospital... and other collaboratorsRecruitingSeminoma | Testicular Germ Cell Cancer | Non-Seminoma Testicular Cancer | Stage I Testicular Cancer | Stage II Testicular Cancer | Stage III Testicular Cancer | Stage IV Testicular Cancer | Relapse Testicular CancerNorway, Sweden
-
University Medical Center GroningenDutch Cancer SocietyCompletedNon-seminomatous Testicular CancerNetherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedTesticular Seminoma | Testicular Yolk Sac Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular Germ Cell Tumor | Ovarian Embryonal Carcinoma | Ovarian Yolk Sac Tumor | Testicular Embryonal Carcinoma | Ovarian Choriocarcinoma | Ovarian Mixed Germ Cell Tumor | Testicular Choriocarcinoma and other conditionsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingSeminoma | Germ Cell Tumor | Metachronous Malignant Neoplasm | Stage I Testicular Cancer AJCC v8 | Stage IA Testicular Cancer AJCC v8 | Stage IB Testicular Cancer AJCC v8 | Stage IS Testicular Cancer AJCC v8Canada, United States, Guam
-
Erasmus Medical CenterRecruitingQuality of Life | Testicular Germ Cell Tumor | Testicular CancerNetherlands
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingLymphadenopathy | Stage I Testicular Seminoma | Stage II Testicular SeminomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedTesticular Yolk Sac Tumor | Recurrent Ovarian Germ Cell Tumor | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent Malignant Testicular Germ Cell Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular Germ Cell Tumor | Ovarian... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
University Medical Center GroningenDutch Cancer SocietyRecruitingTesticular CancerNetherlands
-
Radboud University Medical CenterCompletedTesticular CancerNetherlands
-
Centre Hospitalier Universitaire de NiceTerminatedTesticular CancerFrance
Clinical Trials on Up-positioning of the testes
-
Oslo University HospitalUnknownCorneal Dystrophies, Hereditary | Fuchs' Endothelial Dystrophy | Corneal Transplantation | Descemet Stripping Automated Endothelial KeratoplastyNorway
-
Ankara City Hospital BilkentCompletedAnesthesia Intubation ComplicationTurkey
-
Vanderbilt UniversityCompletedRespiratory FailureUnited States
-
Helse Stavanger HFHaukeland University HospitalCompleted
-
Karadeniz Technical UniversityCompletedPremature InfantsTurkey
-
Francesco PizzaCompletedWound Infection | Incisional Hernia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheTerminated
-
Universidad de ExtremaduraUniversity of ValenciaCompleted
-
Centre Hospitalier René DubosCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)George Washington UniversityRecruiting